ID   RXFP2_HUMAN             Reviewed;         754 AA.
AC   Q8WXD0; B1ALE9; Q3KU23;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   07-OCT-2020, entry version 176.
DE   RecName: Full=Relaxin receptor 2;
DE   AltName: Full=G-protein coupled receptor 106;
DE   AltName: Full=G-protein coupled receptor affecting testicular descent;
DE   AltName: Full=Leucine-rich repeat-containing G-protein coupled receptor 8;
DE   AltName: Full=Relaxin family peptide receptor 2;
GN   Name=RXFP2; Synonyms=GPR106, GREAT, LGR8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF ASP-647.
RX   PubMed=11809971; DOI=10.1126/science.1065654;
RA   Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Sherwood O.D.,
RA   Hsueh A.J.W.;
RT   "Activation of orphan receptors by the hormone relaxin.";
RL   Science 295:671-674(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT CRYPTO PRO-222, AND VARIANT
RP   VAL-604.
RX   PubMed=12217959; DOI=10.1093/hmg/11.19.2309;
RA   Gorlov I.P., Kamat A., Bogatcheva N.V., Jones E., Lamb D.J., Truong A.,
RA   Bishop C.E., McElreavey K., Agoulnik A.I.;
RT   "Mutations of the GREAT gene cause cryptorchidism.";
RL   Hum. Mol. Genet. 11:2309-2318(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=16051677; DOI=10.1093/molehr/gah205;
RA   Muda M., He C., Martini P.G.V., Ferraro T., Layfield S., Taylor D.,
RA   Chevrier C., Schweickhardt R., Kelton C., Ryan P.L., Bathgate R.A.D.;
RT   "Splice variants of the relaxin and INSL3 receptors reveal unanticipated
RT   molecular complexity.";
RL   Mol. Hum. Reprod. 11:591-600(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for relaxin. The activity of this receptor is
CC       mediated by G proteins leading to stimulation of adenylate cyclase and
CC       an increase of cAMP. May also be a receptor for Leydig insulin-like
CC       peptide (INSL3).
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WXD0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WXD0-2; Sequence=VSP_042831;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in the brain, kidney, muscle,
CC       testis, thyroid, uterus, peripheral blood cells and bone marrow.
CC   -!- DISEASE: Cryptorchidism (CRYPTO) [MIM:219050]: One of the most frequent
CC       congenital abnormalities in humans, involving 2-5% of male births.
CC       Cryptorchidism is associated with increased risk of infertility and
CC       testicular cancer. {ECO:0000269|PubMed:12217959}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-18 is the initiator.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF403384; AAL69324.2; -; mRNA.
DR   EMBL; AF453828; AAL73946.1; -; mRNA.
DR   EMBL; AY899851; AAX85199.1; -; mRNA.
DR   EMBL; AL138708; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL159161; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08484.1; -; Genomic_DNA.
DR   CCDS; CCDS53862.1; -. [Q8WXD0-2]
DR   CCDS; CCDS9342.1; -. [Q8WXD0-1]
DR   RefSeq; NP_001159530.1; NM_001166058.1. [Q8WXD0-2]
DR   RefSeq; NP_570718.1; NM_130806.4. [Q8WXD0-1]
DR   PDB; 2M96; NMR; -; A=38-81.
DR   PDBsum; 2M96; -.
DR   BMRB; Q8WXD0; -.
DR   SMR; Q8WXD0; -.
DR   BioGRID; 125757; 1.
DR   STRING; 9606.ENSP00000298386; -.
DR   ChEMBL; CHEMBL1628482; -.
DR   GuidetoPHARMACOLOGY; 352; -.
DR   GlyGen; Q8WXD0; 5 sites.
DR   iPTMnet; Q8WXD0; -.
DR   PhosphoSitePlus; Q8WXD0; -.
DR   BioMuta; RXFP2; -.
DR   DMDM; 21362625; -.
DR   EPD; Q8WXD0; -.
DR   MassIVE; Q8WXD0; -.
DR   PaxDb; Q8WXD0; -.
DR   PeptideAtlas; Q8WXD0; -.
DR   PRIDE; Q8WXD0; -.
DR   ProteomicsDB; 75010; -. [Q8WXD0-1]
DR   ProteomicsDB; 75011; -. [Q8WXD0-2]
DR   Antibodypedia; 22835; 302 antibodies.
DR   DNASU; 122042; -.
DR   Ensembl; ENST00000298386; ENSP00000298386; ENSG00000133105. [Q8WXD0-1]
DR   Ensembl; ENST00000380314; ENSP00000369670; ENSG00000133105. [Q8WXD0-2]
DR   GeneID; 122042; -.
DR   KEGG; hsa:122042; -.
DR   UCSC; uc001utt.4; human. [Q8WXD0-1]
DR   CTD; 122042; -.
DR   DisGeNET; 122042; -.
DR   EuPathDB; HostDB:ENSG00000133105.7; -.
DR   GeneCards; RXFP2; -.
DR   HGNC; HGNC:17318; RXFP2.
DR   HPA; ENSG00000133105; Tissue enhanced (brain, epididymis).
DR   MalaCards; RXFP2; -.
DR   MIM; 219050; phenotype.
DR   MIM; 606655; gene.
DR   neXtProt; NX_Q8WXD0; -.
DR   OpenTargets; ENSG00000133105; -.
DR   PharmGKB; PA134918556; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG2087; Eukaryota.
DR   GeneTree; ENSGT00940000158948; -.
DR   HOGENOM; CLU_006130_2_1_1; -.
DR   InParanoid; Q8WXD0; -.
DR   KO; K04307; -.
DR   OMA; MESLECR; -.
DR   OrthoDB; 559381at2759; -.
DR   PhylomeDB; Q8WXD0; -.
DR   TreeFam; TF326185; -.
DR   PathwayCommons; Q8WXD0; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-444821; Relaxin receptors.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SIGNOR; Q8WXD0; -.
DR   BioGRID-ORCS; 122042; 2 hits in 861 CRISPR screens.
DR   ChiTaRS; RXFP2; human.
DR   GeneWiki; Relaxin/insulin-like_family_peptide_receptor_2; -.
DR   GenomeRNAi; 122042; -.
DR   Pharos; Q8WXD0; Tbio.
DR   PRO; PR:Q8WXD0; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q8WXD0; protein.
DR   Bgee; ENSG00000133105; Expressed in monocyte and 50 other tissues.
DR   Genevisible; Q8WXD0; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0017046; F:peptide hormone binding; IEA:Ensembl.
DR   GO; GO:0016500; F:protein-hormone receptor activity; IEA:Ensembl.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0001556; P:oocyte maturation; IEA:Ensembl.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   CDD; cd00112; LDLa; 1.
DR   Gene3D; 3.80.10.10; -; 2.
DR   Gene3D; 4.10.400.10; -; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008112; Relaxin_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF00057; Ldl_recept_a; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01739; RELAXINR.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00369; LRR_TYP; 10.
DR   SUPFAM; SSF57424; SSF57424; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS51450; LRR; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disease mutation;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Leucine-rich repeat; Membrane; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..754
FT                   /note="Relaxin receptor 2"
FT                   /id="PRO_0000069702"
FT   TOPO_DOM        1..416
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        417..437
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        438..455
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        456..476
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        477..495
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        496..518
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        519..537
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        538..558
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        559..592
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        593..613
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        614..639
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        640..660
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        661..670
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        671..691
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        692..754
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          44..81
FT                   /note="LDL-receptor class A"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   REPEAT          138..159
FT                   /note="LRR 1"
FT   REPEAT          162..183
FT                   /note="LRR 2"
FT   REPEAT          186..207
FT                   /note="LRR 3"
FT   REPEAT          210..231
FT                   /note="LRR 4"
FT   REPEAT          234..255
FT                   /note="LRR 5"
FT   REPEAT          258..279
FT                   /note="LRR 6"
FT   REPEAT          282..303
FT                   /note="LRR 7"
FT   REPEAT          306..327
FT                   /note="LRR 8"
FT   REPEAT          330..351
FT                   /note="LRR 9"
FT   REPEAT          354..375
FT                   /note="LRR 10"
FT   CARBOHYD        54
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        274
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        335
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        378
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        45..58
FT                   /evidence="ECO:0000250"
FT   DISULFID        52..71
FT                   /evidence="ECO:0000250"
FT   DISULFID        65..80
FT                   /evidence="ECO:0000250"
FT   DISULFID        495..573
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         286..309
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16051677"
FT                   /id="VSP_042831"
FT   VARIANT         222
FT                   /note="T -> P (in CRYPTO; functionally inactive;
FT                   dbSNP:rs121918303)"
FT                   /evidence="ECO:0000269|PubMed:12217959"
FT                   /id="VAR_015386"
FT   VARIANT         604
FT                   /note="I -> V (in dbSNP:rs17076657)"
FT                   /evidence="ECO:0000269|PubMed:12217959"
FT                   /id="VAR_015387"
FT   MUTAGEN         647
FT                   /note="D->Y: Leads to constitutive increase of basal cAMP."
FT                   /evidence="ECO:0000269|PubMed:11809971"
FT   HELIX           61..63
FT                   /evidence="ECO:0000244|PDB:2M96"
FT   STRAND          70..75
FT                   /evidence="ECO:0000244|PDB:2M96"
SQ   SEQUENCE   754 AA;  86453 MW;  2088ECD204C6A6C5 CRC64;
     MIVFLVFKHL FSLRLITMFF LLHFIVLINV KDFALTQGSM ITPSCQKGYF PCGNLTKCLP
     RAFHCDGKDD CGNGADEENC GDTSGWATIF GTVHGNANSV ALTQECFLKQ YPQCCDCKET
     ELECVNGDLK SVPMISNNVT LLSLKKNKIH SLPDKVFIKY TKLKKIFLQH NCIRHISRKA
     FFGLCNLQIL YLNHNCITTL RPGIFKDLHQ LTWLILDDNP ITRISQRLFT GLNSLFFLSM
     VNNYLEALPK QMCAQMPQLN WVDLEGNRIK YLTNSTFLSC DSLTVLFLPR NQIGFVPEKT
     FSSLKNLGEL DLSSNTITEL SPHLFKDLKL LQKLNLSSNP LMYLHKNQFE SLKQLQSLDL
     ERIEIPNINT RMFQPMKNLS HIYFKNFRYC SYAPHVRICM PLTDGISSFE DLLANNILRI
     FVWVIAFITC FGNLFVIGMR SFIKAENTTH AMSIKILCCA DCLMGVYLFF VGIFDIKYRG
     QYQKYALLWM ESVQCRLMGF LAMLSTEVSV LLLTYLTLEK FLVIVFPFSN IRPGKRQTSV
     ILICIWMAGF LIAVIPFWNK DYFGNFYGKN GVCFPLYYDQ TEDIGSKGYS LGIFLGVNLL
     AFLIIVFSYI TMFCSIQKTA LQTTEVRNCF GREVAVANRF FFIVFSDAIC WIPVFVVKIL
     SLFRVEIPDT MTSWIVIFFL PVNSALNPIL YTLTTNFFKD KLKQLLHKHQ RKSIFKIKKK
     SLSTSIVWIE DSSSLKLGVL NKITLGDSIM KPVS
//
ID   SMO_HUMAN               Reviewed;         787 AA.
AC   Q99835; A4D1K5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   07-OCT-2020, entry version 201.
DE   RecName: Full=Smoothened homolog;
DE            Short=SMO;
DE   AltName: Full=Protein Gx;
DE   Flags: Precursor;
GN   Name=SMO; Synonyms=SMOH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Embryonic lung;
RX   PubMed=8906787; DOI=10.1038/384129a0;
RA   Stone D.M., Hynes M., Armanini M., Swanson T.A., Gu Q., Johnson R.L.,
RA   Scott M.P., Pennica D., Goddard A., Phillips H., Noll M., Hooper J.E.,
RA   de Sauvage F., Rosenthal A.;
RT   "The tumour-suppressor gene patched encodes a candidate receptor for Sonic
RT   hedgehog.";
RL   Nature 384:129-134(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-535 AND GLN-562.
RX   PubMed=9422511; DOI=10.1038/34201;
RA   Xie J., Murone M., Luoh S.-M., Ryan A., Gu Q., Zhang C., Bonifas J.M.,
RA   Lam C.-W., Hynes M., Goddard A., Rosenthal A., Epstein E.H. Jr.,
RA   de Sauvage F.J.;
RT   "Activating Smoothened mutations in sporadic basal-cell carcinoma.";
RL   Nature 391:90-92(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Jiang N., Zeng Z.Y., Li G.Y.;
RT   "Cloning and identification of Gx gene in NPC.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH KIF7.
RX   PubMed=19592253; DOI=10.1016/j.cub.2009.06.046;
RA   Endoh-Yamagami S., Evangelista M., Wilson D., Wen X., Theunissen J.W.,
RA   Phamluong K., Davis M., Scales S.J., Solloway M.J., de Sauvage F.J.,
RA   Peterson A.S.;
RT   "The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh
RT   signal transduction during development.";
RL   Curr. Biol. 19:1320-1326(2009).
RN   [8]
RP   INTERACTION WITH GAS8.
RX   PubMed=21659505; DOI=10.1074/jbc.m111.234666;
RA   Evron T., Philipp M., Lu J., Meloni A.R., Burkhalter M., Chen W.,
RA   Caron M.G.;
RT   "Growth arrest specific 8 (Gas8) and G protein-coupled receptor kinase 2
RT   (GRK2) cooperate in the control of Smoothened signaling.";
RL   J. Biol. Chem. 286:27676-27686(2011).
RN   [9]
RP   ASSOCIATION WITH THE BBSOME COMPLEX, INTERACTION WITH BBS5 AND BBS7, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22072986; DOI=10.1371/journal.pgen.1002358;
RA   Seo S., Zhang Q., Bugge K., Breslow D.K., Searby C.C., Nachury M.V.,
RA   Sheffield V.C.;
RT   "A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and
RT   Smoothened.";
RL   PLoS Genet. 7:E1002358-E1002358(2011).
RN   [10]
RP   INVOLVEMENT IN CRJS, AND VARIANT CRJS PHE-412.
RX   PubMed=27236920; DOI=10.1016/j.ajhg.2016.04.007;
RA   Twigg S.R., Hufnagel R.B., Miller K.A., Zhou Y., McGowan S.J., Taylor J.,
RA   Craft J., Taylor J.C., Santoro S.L., Huang T., Hopkin R.J., Brady A.F.,
RA   Clayton-Smith J., Clericuzio C.L., Grange D.K., Groesser L., Hafner C.,
RA   Horn D., Temple I.K., Dobyns W.B., Curry C.J., Jones M.C., Wilkie A.O.;
RT   "A recurrent mosaic mutation in SMO, encoding the hedgehog signal
RT   transducer smoothened, is the major cause of Curry-Jones syndrome.";
RL   Am. J. Hum. Genet. 98:1256-1265(2016).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 190-555 IN COMPLEX WITH
RP   ANTAGONIST, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=23636324; DOI=10.1038/nature12167;
RA   Wang C., Wu H., Katritch V., Han G.W., Huang X.P., Liu W., Siu F.Y.,
RA   Roth B.L., Cherezov V., Stevens R.C.;
RT   "Structure of the human smoothened receptor bound to an antitumour agent.";
RL   Nature 497:338-343(2013).
RN   [12]
RP   VARIANT CRJS PHE-412, VARIANT LEU-535, CHARACTERIZATION OF VARIANT CRJS
RP   PHE-412, AND CHARACTERIZATION OF VARIANT LEU-535.
RX   PubMed=24859340; DOI=10.1038/ng.2986;
RA   Sweeney R.T., McClary A.C., Myers B.R., Biscocho J., Neahring L.,
RA   Kwei K.A., Qu K., Gong X., Ng T., Jones C.D., Varma S., Odegaard J.I.,
RA   Sugiyama T., Koyota S., Rubin B.P., Troxell M.L., Pelham R.J.,
RA   Zehnder J.L., Beachy P.A., Pollack J.R., West R.B.;
RT   "Identification of recurrent SMO and BRAF mutations in ameloblastomas.";
RL   Nat. Genet. 46:722-725(2014).
CC   -!- FUNCTION: G protein-coupled receptor that probably associates with the
CC       patched protein (PTCH) to transduce the hedgehog's proteins signal.
CC       Binding of sonic hedgehog (SHH) to its receptor patched is thought to
CC       prevent normal inhibition by patched of smoothened (SMO). Required for
CC       the accumulation of KIF7, GLI2 and GLI3 in the cilia (PubMed:19592253).
CC       Interacts with DLG5 at the ciliary base to induce the accumulation of
CC       KIF7 and GLI2 at the ciliary tip for GLI2 activation (By similarity).
CC       {ECO:0000250|UniProtKB:P56726, ECO:0000269|PubMed:19592253}.
CC   -!- SUBUNIT: Homodimer (PubMed:23636324). Interacts with ARRB2 (By
CC       similarity). Interacts with KIF7 (PubMed:19592253). Interacts with BBS5
CC       and BBS7; the interactions are indicative for the association of SMO
CC       with the BBsome complex to facilitate ciliary localization of SMO
CC       (PubMed:22072986). Interacts with DLG5 and SDCBP (By similarity).
CC       Interacts with GAS8/DRC4 (PubMed:21659505).
CC       {ECO:0000250|UniProtKB:P56726, ECO:0000269|PubMed:19592253,
CC       ECO:0000269|PubMed:21659505, ECO:0000269|PubMed:22072986,
CC       ECO:0000269|PubMed:23636324}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:22072986}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:22072986}. Cell projection,
CC       cilium {ECO:0000269|PubMed:22072986}.
CC   -!- DISEASE: Curry-Jones syndrome (CRJS) [MIM:601707]: A multisystem
CC       disorder characterized by patchy skin lesions, polysyndactyly, diverse
CC       cerebral malformations, unicoronal craniosynostosis, iris colobomas,
CC       microphthalmia, and intestinal malrotation with myofibromas or
CC       hamartomas. {ECO:0000269|PubMed:24859340, ECO:0000269|PubMed:27236920}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry. 8 individuals have been identified with the disease-
CC       causing mutation Phe-412 and all were mosaic. The mutation could not be
CC       reliably detected in blood, greatest success rates were obtained with
CC       affected tissues obtained by invasive procedures. It is thought that
CC       the mutation has arisen postzygotically early during embryonic
CC       development (PubMed:27236920). This mutation has also been identified
CC       in ameloblastoma, medulloblastoma, meningioma, and basal cell
CC       carcinoma, and has been reported as the oncogenic driver in some of
CC       these tumors (PubMed:24859340). {ECO:0000269|PubMed:24859340,
CC       ECO:0000269|PubMed:27236920}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor Fz/Smo family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U84401; AAB41788.1; -; mRNA.
DR   EMBL; AF114821; AAD17202.1; -; Genomic_DNA.
DR   EMBL; AF114819; AAD17202.1; JOINED; Genomic_DNA.
DR   EMBL; AF114820; AAD17202.1; JOINED; Genomic_DNA.
DR   EMBL; AF120103; AAF31757.1; -; mRNA.
DR   EMBL; AF071494; AAC24863.1; -; mRNA.
DR   EMBL; CH236950; EAL24102.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83715.1; -; Genomic_DNA.
DR   EMBL; BC009989; AAH09989.1; -; mRNA.
DR   CCDS; CCDS5811.1; -.
DR   RefSeq; NP_005622.1; NM_005631.4.
DR   PDB; 4JKV; X-ray; 2.45 A; A/B=190-555.
DR   PDB; 4N4W; X-ray; 2.80 A; A=190-555.
DR   PDB; 4O9R; X-ray; 3.20 A; A=190-433, A=441-555.
DR   PDB; 4QIM; X-ray; 2.61 A; A=190-433, A=441-555.
DR   PDB; 4QIN; X-ray; 2.60 A; A=190-433, A=441-555.
DR   PDB; 5L7D; X-ray; 3.20 A; A/B=32-428, A/B=443-555.
DR   PDB; 5L7I; X-ray; 3.30 A; A/B=32-428, A/B=443-555.
DR   PDB; 5V56; X-ray; 2.90 A; A/B=53-437, A/B=444-558.
DR   PDB; 5V57; X-ray; 3.00 A; A/B=58-437, A/B=444-558.
DR   PDB; 6OT0; EM; 3.90 A; R=1-555.
DR   PDBsum; 4JKV; -.
DR   PDBsum; 4N4W; -.
DR   PDBsum; 4O9R; -.
DR   PDBsum; 4QIM; -.
DR   PDBsum; 4QIN; -.
DR   PDBsum; 5L7D; -.
DR   PDBsum; 5L7I; -.
DR   PDBsum; 5V56; -.
DR   PDBsum; 5V57; -.
DR   PDBsum; 6OT0; -.
DR   SMR; Q99835; -.
DR   BioGRID; 112492; 11.
DR   DIP; DIP-34574N; -.
DR   IntAct; Q99835; 34.
DR   MINT; Q99835; -.
DR   STRING; 9606.ENSP00000249373; -.
DR   BindingDB; Q99835; -.
DR   ChEMBL; CHEMBL5971; -.
DR   DrugBank; DB01047; Fluocinonide.
DR   DrugBank; DB11978; Glasdegib.
DR   DrugBank; DB06786; Halcinonide.
DR   DrugBank; DB09143; Sonidegib.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugCentral; Q99835; -.
DR   GuidetoPHARMACOLOGY; 239; -.
DR   TCDB; 9.A.14.16.4; the g-protein-coupled receptor (gpcr) family.
DR   GlyConnect; 2079; 1 N-Linked glycan (1 site).
DR   GlyGen; Q99835; 5 sites, 1 N-linked glycan (1 site), 2 O-linked glycans (2 sites).
DR   iPTMnet; Q99835; -.
DR   PhosphoSitePlus; Q99835; -.
DR   BioMuta; SMO; -.
DR   DMDM; 6226142; -.
DR   EPD; Q99835; -.
DR   jPOST; Q99835; -.
DR   MassIVE; Q99835; -.
DR   PaxDb; Q99835; -.
DR   PeptideAtlas; Q99835; -.
DR   PRIDE; Q99835; -.
DR   ProteomicsDB; 78499; -.
DR   Antibodypedia; 31982; 570 antibodies.
DR   DNASU; 6608; -.
DR   Ensembl; ENST00000249373; ENSP00000249373; ENSG00000128602.
DR   GeneID; 6608; -.
DR   KEGG; hsa:6608; -.
DR   UCSC; uc003vor.4; human.
DR   CTD; 6608; -.
DR   DisGeNET; 6608; -.
DR   EuPathDB; HostDB:ENSG00000128602.9; -.
DR   GeneCards; SMO; -.
DR   HGNC; HGNC:11119; SMO.
DR   HPA; ENSG00000128602; Low tissue specificity.
DR   MalaCards; SMO; -.
DR   MIM; 601500; gene.
DR   MIM; 601707; phenotype.
DR   neXtProt; NX_Q99835; -.
DR   OpenTargets; ENSG00000128602; -.
DR   Orphanet; 1553; Curry-Jones syndrome.
DR   PharmGKB; PA35968; -.
DR   eggNOG; KOG3577; Eukaryota.
DR   GeneTree; ENSGT00940000157206; -.
DR   HOGENOM; CLU_007873_3_1_1; -.
DR   InParanoid; Q99835; -.
DR   KO; K06226; -.
DR   OMA; DMHAYIA; -.
DR   OrthoDB; 385042at2759; -.
DR   PhylomeDB; Q99835; -.
DR   TreeFam; TF106460; -.
DR   PathwayCommons; Q99835; -.
DR   Reactome; R-HSA-373080; Class B/2 (Secretin family receptors).
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   Reactome; R-HSA-5620922; BBSome-mediated cargo-targeting to cilium.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5635838; Activation of SMO.
DR   SignaLink; Q99835; -.
DR   SIGNOR; Q99835; -.
DR   BioGRID-ORCS; 6608; 10 hits in 873 CRISPR screens.
DR   ChiTaRS; SMO; human.
DR   GeneWiki; Smoothened; -.
DR   GenomeRNAi; 6608; -.
DR   Pharos; Q99835; Tclin.
DR   PRO; PR:Q99835; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q99835; protein.
DR   Bgee; ENSG00000128602; Expressed in stomach and 195 other tissues.
DR   ExpressionAtlas; Q99835; baseline and differential.
DR   Genevisible; Q99835; HS.
DR   GO; GO:0060170; C:ciliary membrane; TAS:Reactome.
DR   GO; GO:0097542; C:ciliary tip; TAS:Reactome.
DR   GO; GO:0005929; C:cilium; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; IBA:GO_Central.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005113; F:patched binding; IPI:BHF-UCL.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0048143; P:astrocyte activation; IEA:Ensembl.
DR   GO; GO:0060413; P:atrial septum morphogenesis; IEA:Ensembl.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0071397; P:cellular response to cholesterol; ISS:BHF-UCL.
DR   GO; GO:0007417; P:central nervous system development; IBA:GO_Central.
DR   GO; GO:0021953; P:central nervous system neuron differentiation; IEA:Ensembl.
DR   GO; GO:0021696; P:cerebellar cortex morphogenesis; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0071679; P:commissural neuron axon guidance; IBA:GO_Central.
DR   GO; GO:0060242; P:contact inhibition; IMP:BHF-UCL.
DR   GO; GO:0021542; P:dentate gyrus development; IEA:Ensembl.
DR   GO; GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; ISS:BHF-UCL.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0060684; P:epithelial-mesenchymal cell signaling; IEA:Ensembl.
DR   GO; GO:0048853; P:forebrain morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0070986; P:left/right axis specification; IEA:Ensembl.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0072285; P:mesenchymal to epithelial transition involved in metanephric renal vesicle formation; ISS:UniProtKB.
DR   GO; GO:0007494; P:midgut development; ISS:BHF-UCL.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0051451; P:myoblast migration; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0043392; P:negative regulation of DNA binding; ISS:UniProtKB.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0051799; P:negative regulation of hair follicle development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0001755; P:neural crest cell migration; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0061113; P:pancreas morphogenesis; IEA:Ensembl.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:ARUK-UCL.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0007228; P:positive regulation of hh target transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0046622; P:positive regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0042307; P:positive regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IEA:Ensembl.
DR   GO; GO:2000826; P:regulation of heart morphogenesis; ISS:BHF-UCL.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IEA:Ensembl.
DR   GO; GO:0048745; P:smooth muscle tissue development; IEP:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; IMP:UniProtKB.
DR   GO; GO:0021938; P:smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0021910; P:smoothened signaling pathway involved in ventral spinal cord patterning; IEA:Ensembl.
DR   GO; GO:0061053; P:somite development; ISS:BHF-UCL.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   GO; GO:0003323; P:type B pancreatic cell development; IEA:Ensembl.
DR   GO; GO:0001570; P:vasculogenesis; IEA:Ensembl.
DR   GO; GO:0007371; P:ventral midline determination; ISS:BHF-UCL.
DR   CDD; cd07451; CRD_SMO; 1.
DR   Gene3D; 1.10.2000.10; -; 1.
DR   InterPro; IPR015526; Frizzled/SFRP.
DR   InterPro; IPR000539; Frizzled/Smoothened_TM.
DR   InterPro; IPR020067; Frizzled_dom.
DR   InterPro; IPR036790; Frizzled_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like.
DR   InterPro; IPR026544; SMO.
DR   InterPro; IPR041771; SMO_CRD.
DR   PANTHER; PTHR11309; PTHR11309; 1.
DR   PANTHER; PTHR11309:SF35; PTHR11309:SF35; 1.
DR   Pfam; PF01534; Frizzled; 1.
DR   Pfam; PF01392; Fz; 1.
DR   PRINTS; PR00489; FRIZZLED.
DR   SMART; SM00063; FRI; 1.
DR   SMART; SM01330; Frizzled; 1.
DR   SUPFAM; SSF63501; SSF63501; 1.
DR   PROSITE; PS50038; FZ; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell projection; Developmental protein; Disease mutation;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Signal; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..787
FT                   /note="Smoothened homolog"
FT                   /id="PRO_0000013015"
FT   TOPO_DOM        28..233
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        234..254
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        255..262
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        263..283
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        284..314
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        315..335
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        336..358
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        359..379
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        380..402
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        403..423
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        424..451
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        452..472
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        473..524
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        525..545
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        546..787
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          65..181
FT                   /note="FZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   REGION          538..569
FT                   /note="Interaction with BBS5 and BBS7"
FT                   /evidence="ECO:0000269|PubMed:22072986"
FT   REGION          581..593
FT                   /note="Interaction with DLG5"
FT                   /evidence="ECO:0000250|UniProtKB:P56726"
FT   CARBOHYD        35
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        309
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        70..134
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        78..127
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        118..154
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        147..169
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090"
FT   DISULFID        193..213
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:23636324"
FT   DISULFID        217..295
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:23636324"
FT   DISULFID        314..390
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:23636324"
FT   DISULFID        490..507
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00090,
FT                   ECO:0000269|PubMed:23636324"
FT   VARIANT         412
FT                   /note="L -> F (in CRJS; constitutive activation of the
FT                   smoothened signaling pathway; dbSNP:rs879255280)"
FT                   /evidence="ECO:0000269|PubMed:24859340,
FT                   ECO:0000269|PubMed:27236920"
FT                   /id="VAR_077087"
FT   VARIANT         473
FT                   /note="D -> H (in dbSNP:rs17710891)"
FT                   /id="VAR_037891"
FT   VARIANT         535
FT                   /note="W -> L (in basal cell carcinoma and ameloblastoma
FT                   samples; somatic mutation; constitutive activation of the
FT                   smoothened signaling pathway; dbSNP:rs121918347)"
FT                   /evidence="ECO:0000269|PubMed:24859340,
FT                   ECO:0000269|PubMed:9422511"
FT                   /id="VAR_007848"
FT   VARIANT         562
FT                   /note="R -> Q (in basal cell carcinoma samples; somatic
FT                   mutation; dbSNP:rs121918348)"
FT                   /evidence="ECO:0000269|PubMed:9422511"
FT                   /id="VAR_007849"
FT   STRAND          65..67
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   STRAND          76..78
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   STRAND          86..88
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   STRAND          90..92
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           99..109
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           110..113
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           116..130
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   STRAND          136..140
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           144..151
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   TURN            152..154
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           155..160
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   TURN            165..167
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   TURN            171..173
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   TURN            182..184
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   STRAND          190..192
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          197..199
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           203..205
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          210..218
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           224..254
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           256..259
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   TURN            262..265
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           266..282
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           283..285
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           289..294
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          299..301
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          304..306
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          308..310
FT                   /evidence="ECO:0000244|PDB:5L7D"
FT   HELIX           313..347
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   TURN            354..356
FT                   /evidence="ECO:0000244|PDB:4QIM"
FT   HELIX           361..378
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          381..384
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   TURN            385..388
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          389..395
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           397..403
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           405..432
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          436..442
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           443..492
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          501..503
FT                   /evidence="ECO:0000244|PDB:5V56"
FT   HELIX           515..532
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           533..536
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   HELIX           539..548
FT                   /evidence="ECO:0000244|PDB:4JKV"
FT   STRAND          554..558
FT                   /evidence="ECO:0000244|PDB:5V57"
SQ   SEQUENCE   787 AA;  86397 MW;  8B4C459B34D13F83 CRC64;
     MAAARPARGP ELPLLGLLLL LLLGDPGRGA ASSGNATGPG PRSAGGSARR SAAVTGPPPP
     LSHCGRAAPC EPLRYNVCLG SVLPYGATST LLAGDSDSQE EAHGKLVLWS GLRNAPRCWA
     VIQPLLCAVY MPKCENDRVE LPSRTLCQAT RGPCAIVERE RGWPDFLRCT PDRFPEGCTN
     EVQNIKFNSS GQCEVPLVRT DNPKSWYEDV EGCGIQCQNP LFTEAEHQDM HSYIAAFGAV
     TGLCTLFTLA TFVADWRNSN RYPAVILFYV NACFFVGSIG WLAQFMDGAR REIVCRADGT
     MRLGEPTSNE TLSCVIIFVI VYYALMAGVV WFVVLTYAWH TSFKALGTTY QPLSGKTSYF
     HLLTWSLPFV LTVAILAVAQ VDGDSVSGIC FVGYKNYRYR AGFVLAPIGL VLIVGGYFLI
     RGVMTLFSIK SNHPGLLSEK AASKINETML RLGIFGFLAF GFVLITFSCH FYDFFNQAEW
     ERSFRDYVLC QANVTIGLPT KQPIPDCEIK NRPSLLVEKI NLFAMFGTGI AMSTWVWTKA
     TLLIWRRTWC RLTGQSDDEP KRIKKSKMIA KAFSKRHELL QNPGQELSFS MHTVSHDGPV
     AGLAFDLNEP SADVSSAWAQ HVTKMVARRG AILPQDISVT PVATPVPPEE QANLWLVEAE
     ISPELQKRLG RKKKRRKRKK EVCPLAPPPE LHPPAPAPST IPRLPQLPRQ KCLVAAGAWG
     AGDSCRQGAW TLVSNPFCPE PSPPQDPFLP SAPAPVAWAH GRRQGLGPIH SRTNLMDTEL
     MDADSDF
//
